Enveric Biosciences Appoints New Auditor
Ticker: ENVB · Form: 8-K · Filed: Apr 14, 2025 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, financial-reporting
TL;DR
Enveric swapped auditors, bringing in Marcum LLP.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on April 14, 2025, to report changes in its certifying accountant. The company has appointed Marcum LLP as its new independent registered public accounting firm, replacing WithumSmith+Brown, PC.
Why It Matters
A change in auditors can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting.
Risk Assessment
Risk Level: medium — Changes in auditors can sometimes precede or coincide with financial restatements or other financial reporting concerns.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- Marcum LLP (company) — New Certifying Accountant
- WithumSmith+Brown, PC (company) — Former Certifying Accountant
- April 14, 2025 (date) — Filing Date
FAQ
When was Marcum LLP appointed as Enveric Biosciences' new certifying accountant?
The filing does not specify an exact appointment date, but it is reported on April 14, 2025, indicating the change is effective around this time.
Who was Enveric Biosciences' previous certifying accountant?
Enveric Biosciences' previous certifying accountant was WithumSmith+Brown, PC.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a change in Enveric Biosciences, Inc.'s certifying accountant.
Did Enveric Biosciences have any disagreements with their former auditor, WithumSmith+Brown, PC?
The filing does not mention any disagreements between Enveric Biosciences and WithumSmith+Brown, PC.
What is Enveric Biosciences' principal executive office address?
Enveric Biosciences' principal executive office is located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2025 regarding Enveric Biosciences, Inc. (ENVB).